Cancer SurvivorshipFMW-UKNCT07356726
Finding My Way-UK: Promoting Positive Psychological Outcomes in People Living With and Beyond Curatively Treated Cancer
A study testing Finding My Way-UK in people with Cancer Survivorship and Cancer, run by Edge Hill University at 1 site in United Kingdom.
Trial summary
The goal of this pilot randomised trial is to evaluate whether an online psychosocial intervention (Finding My Way-UK) is feasible and acceptable for individuals living with and beyond curatively treated cancer. The main questions it aims to answer are: 1. Read more about this study
- Who is it for?
- Ages 16 years and older
- Conditions the study is for
- Cancer Survivorship, Cancer, Neoplasms
- What is being tested?
- Finding My Way-UK
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Jan 2026to Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Diagnosed with any cancer within the past 12 months;
- Cancer is being (or, indeed, was) treated with curative intent;
- Aged 16 years or older;
- Possess sufficient English proficiency to provide informed consent and use the program;
- Able to access the internet and have access to an email address (or are willing to set an email address up with our help).
Who cannot join
- Diagnosis of cancer not being treated with curative intent (for example, metastatic, stage IV, or otherwise advanced-stage disease);
- And/Or have a severe comorbidity that may hinder their ability to participate fully (such as being unable to complete study procedures or provide informed consent).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Nicholas J Hulbert-Williams, PhD contact
United Kingdom1 site
Edge Hill University - Department of Psychology
Ormskirk, Lancashire, L39 4QP
Kian Hughes, PhD Candidate, +44 01695 584508, hugheski@edgehill.ac.uk
About this study
Official title: Finding My Way-UK: Promoting Positive Psychological Outcomes in People Living With and Beyond Curatively Treated Cancer: A Pilot Randomised Trial
The goal of this pilot randomised trial is to evaluate whether an online psychosocial intervention (Finding My Way-UK) is feasible and acceptable for individuals living with and beyond curatively treated cancer. The main questions it aims to answer are:
- Is Finding My Way-UK feasible and acceptable for individuals living with and beyond curatively treated cancer?
- Are there preliminary signals of efficacy in benefit finding and other well-being outcomes (hope, resilience, and subjective well-being)?
- What is the potential role of information-seeking styles and self-management self-efficacy?
Read more
Participants will be randomly assigned to one of two groups:
- Finding My Way-UK Intervention group: access a four-week, self-guided online program with six modules covering coping with treatment side effects, managing emotions, social support, body image, and post-treatment adjustment.
- Control group: receive a digital information pack listing national psychological support resources.
All study activities will take place online. Participants will complete questionnaires before the program, after four weeks, and three months later.
Read the detailed description
Finding My Way-UK is a broad psychosocial intervention that integrates theoretical foundations from cognitive-behavioural therapy, psychoeducation, and exercises from third-wave approaches such as mindfulness meditation. Originally developed in Australia, the program demonstrated efficacy in reducing distress among women with breast cancer. It has since been culturally adapted for the UK cancer-care context and previously underwent a pilot trial assessing its applicability to UK participants and preliminary signals of efficacy on distress outcomes.
Based on feedback from that earlier trial, several design modifications have been introduced to enhance feasibility and engagement: (i) The intervention duration has been reduced from six weeks to four weeks; and (ii) Participants will have immediate access to all six modules upon logging in, rather than the previous sequential weekly release. Additionally, recruitment will be conducted entirely online through collaborations with cancer charities and social-media outreach.
To the best of our knowledge, this represents the first online, self-guided, broad psychosocial intervention that aims to assess positive psychological outcomes in individuals living with and beyond curatively treated cancer. This pilot trial is therefore intended to evaluate the feasibility and acceptability of the revised design and to provide preliminary data to inform a future, fully powered randomised controlled trial.
Benefit finding, hope, resilience, and subjective well-being will be assessed to explore preliminary signals of efficacy. Given the pilot nature of the study and the modest sample size, analyses of these outcomes will be descriptive and exploratory only, focusing on effect-size estimation and clinically meaningful change rather than formal hypothesis testing.
- Conditions
- Cancer Survivorship, Cancer, Neoplasms
- Being tested
- Finding My Way-UK, Treatment-As-Usual Control
- Keywords
- Cancer Survivorship, Benefit Finding, Psychosocial Intervention, Acceptability, Feasibility, Pilot Randomised Trial, Resilience, Hope, Subjective Well-Being, Curatively Treated, Online Intervention, Psycho-Oncology
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Finding My Way-UKBehavioural
Also called FMW-UK
Self-guided, web-based psychosocial intervention integrating cognitive-behavioural, psychoeducational, and mindfulness-based strategies to support people living with and beyond curatively treated cancer. Six modules delivered online; participants complete flexibly over four weeks.
Treatment-As-Usual ControlOther
Also called Information Pack Control
Digital information pack (PDF) signposting to existing UK cancer-support organisations and psychological resources. Distributed by email; no structured therapeutic program or study-specific content.
| Study group | Role | What they receive |
|---|---|---|
| Finding My Way-UK Intervention | Experimental | Participants receive immediate access to the Finding My Way-UK online psychosocial program for four weeks. The program includes six self-guided modules on topics such as: treatment and communication with treatment teams, coping with treatment side effects, managing emotions, identity and body image, social support, and post-treatment adjustment. Receives: Behavioral: Finding My Way-UK |
| Control - Information Pack | Other | Participants receive a digital information pack listing national psychological support resources for people living with and beyond cancer (e.g., Macmillan Cancer Support, Maggie's). This arm represents a treatment-as-usual control providing publicly available information but no structured psychosocial content. Receives: Other: Treatment-As-Usual Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment Rate
The feasibility of recruitment will be assessed by the number of participants enrolled in the study per month.
Measured: From enrolment of the first participant until the recruitment target is reached (up to 6 months)
Intervention Adherence: Modules Accessed
The level of engagement with the Finding My Way-UK program, defined as the number of intervention modules accessed (opened) by each participant on the Finding My Way-UK platform.
Measured: At post-intervention (week 4)
Intervention Adherence: Modules Completed
The number of intervention modules completed by each participant on the Finding My Way-UK platform.
Measured: At post-intervention (week 4)
Retention Rate at Post-Intervention
Assessed by the percentage of participants who complete the post-intervention outcome assessment.
Measured: At post-intervention (week 4)
Retention Rate at 3-Month Follow-Up
The percentage of participants who complete the 3-month post-intervention outcome assessment.
Measured: At 3 months post-intervention
Qualitative Acceptability of the Intervention
At baseline, participants will be asked an open-ended question about their expectations for the intervention, specifically what they hope will change or improve. At follow-up, participants will provide free-text responses describing any unexpected changes or impacts. Free-text responses will be subjected to basic thematic analysis to identify common themes relating to participant experience and acceptability.
Measured: At post-intervention (week 4)
Quantitative Acceptability of the Intervention
At baseline, participants will be asked an open-ended question about their expectations for the intervention, specifically what they hope will change or improve. At follow-up, participants rate the extent to which the intervention met these expectations on a Likert scale ranging from 1 (not at all) to 10 (completely). Higher scores indicate greater acceptability.
Measured: At post-intervention (week 4)
Secondary outcomes (4)
Change from Baseline in Benefit Finding Score
Measured using the Benefit Finding Scale (BFS). The BFS contains 17 items rated from 1 = not at all to 5 = extremely, summed to a total score range of 17-85, with higher scores indicating greater benefit finding. Analyses will be descriptive and exploratory, focusing on estimating pre-post effect sizes and the proportion of participants showing reliable improvement using Reliable Change Indices; no formal hypothesis testing will be performed.
Measured: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Change from Baseline in Satisfaction with Life
Subjective well-being will be assessed with the Satisfaction with Life Scale (SWLS). The SWLS comprises 5 items rated from 1 = strongly disagree to 7 = strongly agree, summed to give a total score range of 5-35, where higher scores reflect greater life satisfaction.
Measured: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Change from Baseline in Hope
Measured using the Herth Hope Index (HHI). The HHI includes 12 items rated 1 = strongly disagree to 4 = strongly agree, summed for a total score range of 12-48; higher values indicate greater hope.
Measured: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Change from Baseline in Resilience
Measured using the Connor-Davidson Resilience Scale-10 (CD-RISC-10). Ten items rated 0 (not true at all) to 4 (true nearly all the time) yield a total score range of 0-40, with higher scores indicating greater resilience.
Measured: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jan 2026
- Study startJan 2026 (estimated)
- Primary completionJul 2026 (estimated)
- Study completionJul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Cancer SurvivorshipStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomised 1:1 to the Finding My Way-UK intervention or a treatment-as-usual control group, with both arms running concurrently.
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Edge Hill University
- Sponsor type
- University, hospital or other
- Collaborators
- Flinders University
- Responsible party
- Sponsor
- Investigators
- Kian Hughes, PhD Candidate, Principal investigator, Edge Hill University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07356726
- Sponsor's protocol ID
- ETH2425-0268
- Acronym
- FMW-UK
- Status last verified
- Jan 2026
- First submitted
- 8 Dec 2025
- Last updated
- 21 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Loiselle CG. Cancer information-seeking preferences linked to distinct patient experiences and differential satisfaction with cancer care. Patient Educ Couns. 2019 Jun;102(6):1187-1193. doi: 10.1016/j.pec.2019.01.009. Epub 2019 Jan 18.
PubMed 30685191Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001 Nov-Dec;4(6):256-62.
PubMed 11769298Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress. 2007 Dec;20(6):1019-28. doi: 10.1002/jts.20271.
PubMed 18157881Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct;17(10):1251-9. doi: 10.1111/j.1365-2648.1992.tb01843.x.
PubMed 1430629Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13.
PubMed 16367493Hulbert-Williams NJ, Leslie M, Hulbert-Williams L, Koczwara B, Watson EK, Hall PS, Ashley L, Coulson NS, Jackson R, Millington S; Finding My Way UK Trial Steering Group; Beatty L. The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer Survivors. JMIR Res Protoc. 2021 Sep 20;10(9):e31976. doi: 10.2196/31976.
PubMed 34542420Beatty L, Kemp E, Coll JR, Turner J, Butow P, Milne D, Yates P, Lambert S, Wootten A, Yip D, Koczwara B. Finding My Way: results of a multicentre RCT evaluating a web-based self-guided psychosocial intervention for newly diagnosed cancer survivors. Support Care Cancer. 2019 Jul;27(7):2533-2544. doi: 10.1007/s00520-018-4526-1. Epub 2018 Nov 9.
PubMed 30411239Beatty L, Koczwara B, Wade T. Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancer-distress: a randomised controlled trial. Support Care Cancer. 2016 Mar;24(3):1043-51. doi: 10.1007/s00520-015-2867-6. Epub 2015 Aug 7.
PubMed 26248651Beatty L, Kemp E, Wade T, Koczwara B; Finding My Way study investigators. Finding My Way: protocol of a randomised controlled trial evaluating an internet self-help program for cancer-related distress. BMC Cancer. 2015 Apr 30;15:328. doi: 10.1186/s12885-015-1322-x.
PubMed 25924674Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001 Jan;20(1):20-32. doi: 10.1037//0278-6133.20.1.20.
PubMed 11199062
Study at a glance
From the registry record, last updated by the sponsor on 21 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Finding My Way-UK: Promoting Positive Psychological Outcomes in People Living With and Beyond Curatively Treated Cancer: A Pilot Randomised Trial
- ClinicalTrials.gov ID
- NCT07356726
- Acronym / sponsor ID
- FMW-UK / ETH2425-0268
- Conditions
- Cancer Survivorship, Cancer, Neoplasms
- Keywords
- Cancer Survivorship, Benefit Finding, Psychosocial Intervention, Acceptability, Feasibility, Pilot Randomised Trial, Resilience, Hope
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Edge Hill UniversityUniversity, hospital or other
- Collaborators
- Flinders University
- Study start
- Jan 2026 (estimated)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- Jul 2026 (estimated)
- First posted
- 21 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this pilot randomised trial is to evaluate whether an online psychosocial intervention (Finding My Way-UK) is feasible and acceptable for individuals living with and beyond curatively treated cancer. The main questions it aims to answer are:
- Is Finding My Way-UK feasible and acceptable for individuals living with and beyond curatively treated cancer?
- Are there preliminary signals of efficacy in benefit finding and other well-being outcomes (hope, resilience, and subjective well-being)?
- What is the potential role of information-seeking styles and self-management self-efficacy?
Participants will be randomly assigned to one of two groups:
- Finding My Way-UK Intervention group: access a four-week, self-guided online program with six modules covering coping with treatment side effects, managing emotions, social support, body image, and post-treatment adjustment.
- Control group: receive a digital information pack listing national psychological support resources.
All study activities will take place online. Participants will complete questionnaires before the program, after four weeks, and three months later.
Detailed description
Finding My Way-UK is a broad psychosocial intervention that integrates theoretical foundations from cognitive-behavioural therapy, psychoeducation, and exercises from third-wave approaches such as mindfulness meditation. Originally developed in Australia, the program demonstrated efficacy in reducing distress among women with breast cancer. It has since been culturally adapted for the UK cancer-care context and previously underwent a pilot trial assessing its applicability to UK participants and preliminary signals of efficacy on distress outcomes.
Based on feedback from that earlier trial, several design modifications have been introduced to enhance feasibility and engagement: (i) The intervention duration has been reduced from six weeks to four weeks; and (ii) Participants will have immediate access to all six modules upon logging in, rather than the previous sequential weekly release. Additionally, recruitment will be conducted entirely online through collaborations with cancer charities and social-media outreach.
To the best of our knowledge, this represents the first online, self-guided, broad psychosocial intervention that aims to assess positive psychological outcomes in individuals living with and beyond curatively treated cancer. This pilot trial is therefore intended to evaluate the feasibility and acceptability of the revised design and to provide preliminary data to inform a future, fully powered randomised controlled trial.
Benefit finding, hope, resilience, and subjective well-being will be assessed to explore preliminary signals of efficacy. Given the pilot nature of the study and the modest sample size, analyses of these outcomes will be descriptive and exploratory only, focusing on effect-size estimation and clinically meaningful change rather than formal hypothesis testing.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will be randomised 1:1 to the Finding My Way-UK intervention or a treatment-as-usual control group, with both arms running concurrently.
| Arm | Type | Receives |
|---|---|---|
| Finding My Way-UK Intervention | Experimental | Behavioral: Finding My Way-UKParticipants receive immediate access to the Finding My Way-UK online psychosocial program for four weeks. The program includes six self-guided modules on topics such as: treatment and communication with treatment teams, coping with treatment side effects, managing emotions, identity and body image, social support, and post-treatment adjustment. |
| Control - Information Pack | Other | Other: Treatment-As-Usual ControlParticipants receive a digital information pack listing national psychological support resources for people living with and beyond cancer (e.g., Macmillan Cancer Support, Maggie's). This arm represents a treatment-as-usual control providing publicly available information but no structured psychosocial content. |
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Diagnosed with any cancer within the past 12 months;
- Cancer is being (or, indeed, was) treated with curative intent;
- Aged 16 years or older;
- Possess sufficient English proficiency to provide informed consent and use the program;
- Able to access the internet and have access to an email address (or are willing to set an email address up with our help).
Key exclusion criteria (2 listed)
- Diagnosis of cancer not being treated with curative intent (for example, metastatic, stage IV, or otherwise advanced-stage disease);
- And/Or have a severe comorbidity that may hinder their ability to participate fully (such as being unable to complete study procedures or provide informed consent).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Finding My Way-UKAlso: FMW-UKSelf-guided, web-based psychosocial intervention integrating cognitive-behavioural, psychoeducational, and mindfulness-based strategies to support people living with and beyond curatively treated cancer. Six modules delivered online; participants complete flexibly over four weeks. | Behavioural | Finding My Way-UK Intervention |
| Treatment-As-Usual ControlAlso: Information Pack ControlDigital information pack (PDF) signposting to existing UK cancer-support organisations and psychological resources. Distributed by email; no structured therapeutic program or study-specific content. | Other | Control - Information Pack |
Primary outcome
Recruitment Rate
Time frame: From enrolment of the first participant until the recruitment target is reached (up to 6 months)
The feasibility of recruitment will be assessed by the number of participants enrolled in the study per month.
Intervention Adherence: Modules Accessed
Time frame: At post-intervention (week 4)
The level of engagement with the Finding My Way-UK program, defined as the number of intervention modules accessed (opened) by each participant on the Finding My Way-UK platform.
Intervention Adherence: Modules Completed
Time frame: At post-intervention (week 4)
The number of intervention modules completed by each participant on the Finding My Way-UK platform.
Retention Rate at Post-Intervention
Time frame: At post-intervention (week 4)
Assessed by the percentage of participants who complete the post-intervention outcome assessment.
Retention Rate at 3-Month Follow-Up
Time frame: At 3 months post-intervention
The percentage of participants who complete the 3-month post-intervention outcome assessment.
Qualitative Acceptability of the Intervention
Time frame: At post-intervention (week 4)
At baseline, participants will be asked an open-ended question about their expectations for the intervention, specifically what they hope will change or improve. At follow-up, participants will provide free-text responses describing any unexpected changes or impacts. Free-text responses will be subjected to basic thematic analysis to identify common themes relating to participant experience and acceptability.
Quantitative Acceptability of the Intervention
Time frame: At post-intervention (week 4)
At baseline, participants will be asked an open-ended question about their expectations for the intervention, specifically what they hope will change or improve. At follow-up, participants rate the extent to which the intervention met these expectations on a Likert scale ranging from 1 (not at all) to 10 (completely). Higher scores indicate greater acceptability.
4 secondary outcomes
Change from Baseline in Benefit Finding Score
Time frame: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Change from Baseline in Satisfaction with Life
Time frame: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Change from Baseline in Hope
Time frame: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Change from Baseline in Resilience
Time frame: Baseline (pre-intervention), post-intervention (week 4), and 3 months post-intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jan 2026.
- Results publication: PubMed 30685191Loiselle CG. Cancer information-seeking preferences linked to distinct patient experiences and differential satisfaction with cancer care. Patient Educ Couns. 2019 Jun;102(6):1187-1193. doi: 10.1016/j.pec.2019.01.009. Epub 2019 Jan 18.
- Results publication: PubMed 11769298Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001 Nov-Dec;4(6):256-62.
- Results publication: PubMed 18157881Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. J Trauma Stress. 2007 Dec;20(6):1019-28. doi: 10.1002/jts.20271.
- Results publication: PubMed 1430629Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct;17(10):1251-9. doi: 10.1111/j.1365-2648.1992.tb01843.x.
- Results publication: PubMed 16367493Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985 Feb;49(1):71-5. doi: 10.1207/s15327752jpa4901_13.
- Results publication: PubMed 34542420Hulbert-Williams NJ, Leslie M, Hulbert-Williams L, Koczwara B, Watson EK, Hall PS, Ashley L, Coulson NS, Jackson R, Millington S; Finding My Way UK Trial Steering Group; Beatty L. The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer Survivors. JMIR Res Protoc. 2021 Sep 20;10(9):e31976. doi: 10.2196/31976.
- Results publication: PubMed 30411239Beatty L, Kemp E, Coll JR, Turner J, Butow P, Milne D, Yates P, Lambert S, Wootten A, Yip D, Koczwara B. Finding My Way: results of a multicentre RCT evaluating a web-based self-guided psychosocial intervention for newly diagnosed cancer survivors. Support Care Cancer. 2019 Jul;27(7):2533-2544. doi: 10.1007/s00520-018-4526-1. Epub 2018 Nov 9.
- Results publication: PubMed 26248651Beatty L, Koczwara B, Wade T. Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancer-distress: a randomised controlled trial. Support Care Cancer. 2016 Mar;24(3):1043-51. doi: 10.1007/s00520-015-2867-6. Epub 2015 Aug 7.
- Results publication: PubMed 25924674Beatty L, Kemp E, Wade T, Koczwara B; Finding My Way study investigators. Finding My Way: protocol of a randomised controlled trial evaluating an internet self-help program for cancer-related distress. BMC Cancer. 2015 Apr 30;15:328. doi: 10.1186/s12885-015-1322-x.
- Results publication: PubMed 11199062Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001 Jan;20(1):20-32. doi: 10.1037//0278-6133.20.1.20.
Related trials for Cancer Survivorship
Recruiting
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Cancer, Survivorship
Not yet recruitingPhase 2
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission
Not yet recruiting
Multi-level Intervention to Successfully Transition to Adult Care for Survivors of Childhood and Adolescent Cancers: The BRIDGES-YAS! Study
Health Care Transition, Survivorship Care
RecruitingObservational study
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Testicular Cancer, Survivorship
RecruitingObservational study
Breast Cancer Rehabilitation Needs and Service Uptake
Breast Cancer, Cancer Survivorship
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Nicholas J Hulbert-Williams, PhD contact
Kian Hughes, PhD Candidate principal investigator
Edge Hill University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Finding My Way-UK in people with Cancer Survivorship and Cancer, run by Edge Hill University at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Kian Hughes, PhD Candidate (+44 01695 584508, hugheski@edgehill.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment Rate (time frame: From enrolment of the first participant until the recruitment target is reached (up to 6 months)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07356726, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2026; AzTrials last refreshed its copy on 8 Nov 2026.